Cooper Companies (The) (COO) : The value of composite uptick trades was $0.98 million, whereas, the value of composite downtick trades was $2.16 million. The uptick to downtick ratio stood at 0.45 with a negative money flow of ($1.18) Million during Wednesdays trading session. The block trades money flow was negative ($0 million). The transaction of the trades on downticks amounted to $0 million, which confirms investors selling on the strength of price. Cooper Companies (The) (COO) gained 66 cents at $178.96, an increase of 0.37% over the previous days close.
The Cooper Companies Inc. has lost 3.92% in the last five trading days and dropped 4.12% in the last 4 weeks. The Cooper Companies Inc. is up 5.33% in the last 3-month period. Year-to-Date the stock performance stands at 33.35%.
Cooper Companies (The) (COO) : 8 brokerage houses believe that Cooper Companies (The) (COO) is a Strong Buy at current levels. 1 Analyst considers the fundamentals to be worthy of a Buy recommendation. 2 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Cooper Companies (The) (COO). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 11 Wall Street Analysts endorse the stock as a Strong Buy with a rating of 1.45.
Cooper Companies (The) (NYSE:COO): The stock opened at $178.07 and touched an intraday high of $179.26 on Wednesday. During the day, the stock corrected to an intraday low of $177.3, however, the bulls stepped in and pushed the price higher to close in the green at $178.88 with a gain of 0.33% for the day. The total traded volume for the day was 464,192. The stock had closed at $178.3 in the previous trading session.
The Cooper Companies, Inc. (Cooper), is a global medical device company. The Company operates through two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying womens health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital, Office and Fertility Clinic. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism, presbyopia and ocular dryness, and provides innovative contact lens solutions. The CooperVision Companys brands include Biofinity, Avaira and MyDay and CooperSurgical Companys brands include Advincula Arch, SeeClear and Mobius.